RAC1 and head and neck squamous cell carcinoma: Although the exact mechanism of the action of RAC1 inhibitors has not been thoroughly explored, their use as single or combination agents seems to have a synergistic effect with mTOR inhibition that could be considered for the treatment of HNSCC.